• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内皮细胞表达 NKG2D 配体并使抗肿瘤 NK 反应脱敏。

Endothelial cells express NKG2D ligands and desensitize antitumor NK responses.

机构信息

Department of Molecular and Cell Biology, Cancer Research Laboratory, University of California, Berkeley, United States.

出版信息

Elife. 2017 Dec 12;6:e30881. doi: 10.7554/eLife.30881.

DOI:10.7554/eLife.30881
PMID:29231815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5792093/
Abstract

Natural Killer (NK) cells confer protection from tumors and infections by releasing cytotoxic granules and pro-inflammatory cytokines upon recognition of diseased cells. The responsiveness of NK cells to acute stimulation is dynamically tuned by steady-state receptor-ligand interactions of an NK cell with its cellular environment. Here, we demonstrate that in healthy WT mice the NK activating receptor NKG2D is engaged in vivo by one of its ligands, RAE-1ε, which is expressed constitutively by lymph node endothelial cells and highly induced on tumor-associated endothelium. This interaction causes internalization of NKG2D from the NK cell surface and transmits an NK-intrinsic signal that desensitizes NK cell responses globally to acute stimulation, resulting in impaired NK antitumor responses in vivo.

摘要

自然杀伤 (NK) 细胞通过识别病变细胞释放细胞毒性颗粒和促炎细胞因子来提供对肿瘤和感染的保护。NK 细胞对急性刺激的反应性通过 NK 细胞与其细胞环境之间的稳态受体-配体相互作用动态调节。在这里,我们证明在健康的 WT 小鼠中,NK 激活受体 NKG2D 通过其配体之一 RAE-1ε 体内结合,RAE-1ε 由淋巴结内皮细胞组成性表达,并在肿瘤相关内皮细胞上高度诱导。这种相互作用导致 NKG2D 从 NK 细胞表面内化,并传递一种 NK 内在信号,使 NK 细胞对急性刺激的反应普遍脱敏,导致体内 NK 抗肿瘤反应受损。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/2810554aace4/elife-30881-resp-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/5de1b559517a/elife-30881-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/70b5650c0721/elife-30881-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/4ac7e5434211/elife-30881-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/b073a705af5d/elife-30881-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/d5a6040e3417/elife-30881-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/7a3a37764cd1/elife-30881-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/5888d1659ee2/elife-30881-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/573b107e1e43/elife-30881-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/a435ba910b2b/elife-30881-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/f7081d9d3b4a/elife-30881-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/32a1f63aeac2/elife-30881-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/01b29071a74a/elife-30881-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/3539ea6c2dad/elife-30881-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/7412e070b234/elife-30881-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/2810554aace4/elife-30881-resp-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/5de1b559517a/elife-30881-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/70b5650c0721/elife-30881-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/4ac7e5434211/elife-30881-fig1-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/b073a705af5d/elife-30881-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/d5a6040e3417/elife-30881-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/7a3a37764cd1/elife-30881-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/5888d1659ee2/elife-30881-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/573b107e1e43/elife-30881-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/a435ba910b2b/elife-30881-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/f7081d9d3b4a/elife-30881-fig4-figsupp2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/32a1f63aeac2/elife-30881-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/01b29071a74a/elife-30881-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/3539ea6c2dad/elife-30881-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/7412e070b234/elife-30881-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe5c/5792093/2810554aace4/elife-30881-resp-fig1.jpg

相似文献

1
Endothelial cells express NKG2D ligands and desensitize antitumor NK responses.内皮细胞表达 NKG2D 配体并使抗肿瘤 NK 反应脱敏。
Elife. 2017 Dec 12;6:e30881. doi: 10.7554/eLife.30881.
2
CD4(+) NKG2D(+) T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1ε transgenic mice.CD4(+) NKG2D(+) T 细胞在 CD86-RAE-1ε 转基因小鼠中诱导自然杀伤细胞中 NKG2D 的下调。
Immunology. 2014 Mar;141(3):401-15. doi: 10.1111/imm.12203.
3
The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands.热休克蛋白HSP70可促进小鼠自然杀伤细胞对表达诱导性NKG2D配体的肿瘤的活性。
J Immunol. 2007 Oct 15;179(8):5523-33. doi: 10.4049/jimmunol.179.8.5523.
4
NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.巨细胞病毒通过对视黄酸早期诱导1基因分子的病毒gp40调节,损害NKG2D介导的自然杀伤细胞对巨细胞病毒的保护作用。
J Exp Med. 2003 May 19;197(10):1245-53. doi: 10.1084/jem.20021973.
5
Dacarbazine-mediated upregulation of NKG2D ligands on tumor cells activates NK and CD8 T cells and restrains melanoma growth.达卡巴嗪上调肿瘤细胞上的 NKG2D 配体,激活 NK 和 CD8 T 细胞,抑制黑色素瘤生长。
J Invest Dermatol. 2013 Feb;133(2):499-508. doi: 10.1038/jid.2012.273. Epub 2012 Sep 6.
6
Fratricide of natural killer cells dressed with tumor-derived NKG2D ligand.自然杀伤细胞的噬杀作用,由肿瘤衍生的 NKG2D 配体介导。
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9421-6. doi: 10.1073/pnas.1300140110. Epub 2013 May 20.
7
Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.激活型NKG2D受体配体的持续局部表达会损害体内的自然细胞毒性并降低肿瘤免疫监视。
Nat Immunol. 2005 Sep;6(9):928-37. doi: 10.1038/ni1239. Epub 2005 Aug 14.
8
Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon.前沿:AP-1亚基JunB通过调节NKG2D配体RAE-1ε来决定自然杀伤细胞介导的靶细胞杀伤作用。
J Immunol. 2006 Jan 1;176(1):7-11. doi: 10.4049/jimmunol.176.1.7.
9
Distribution of several activating and inhibitory receptors on CD3(-)CD56(+) NK cells in regional lymph nodes of melanoma patients.在黑色素瘤患者区域淋巴结中,CD3(-)CD56(+) NK 细胞上几种激活和抑制受体的分布。
J Surg Res. 2013 Aug;183(2):860-8. doi: 10.1016/j.jss.2013.02.025. Epub 2013 Mar 13.
10
Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.抗肿瘤免疫。一种脱落的NKG2D配体,可促进自然杀伤细胞活化和肿瘤排斥。
Science. 2015 Apr 3;348(6230):136-9. doi: 10.1126/science.1258867. Epub 2015 Mar 5.

引用本文的文献

1
Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances.释放自然杀伤细胞用于肺癌的癌症免疫治疗:生物学挑战与临床进展
J Exp Clin Cancer Res. 2025 Aug 23;44(1):251. doi: 10.1186/s13046-025-03503-7.
2
Linking tumour angiogenesis and tumour immunity.将肿瘤血管生成与肿瘤免疫联系起来。
Nat Rev Immunol. 2025 Aug 14. doi: 10.1038/s41577-025-01211-z.
3
Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression.形态转变:内皮-间充质转化作为癌症进展的驱动因素

本文引用的文献

1
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma.免疫受体 NKG2D 促进肝癌模型中的肿瘤生长。
Nat Commun. 2017 Jan 27;8:13930. doi: 10.1038/ncomms13930.
2
Differential Role of Hematopoietic and Nonhematopoietic Cell Types in the Regulation of NK Cell Tolerance and Responsiveness.造血细胞和非造血细胞类型在自然杀伤细胞耐受性和反应性调节中的不同作用。
J Immunol. 2016 Nov 15;197(10):4127-4136. doi: 10.4049/jimmunol.1402447. Epub 2016 Oct 19.
3
The Self-Specific Activation Receptor SLAM Family Is Critical for NK Cell Education.
Int J Mol Sci. 2025 Jul 1;26(13):6353. doi: 10.3390/ijms26136353.
4
Angiogenesis and targeted therapy in the tumour microenvironment: From basic to clinical practice.肿瘤微环境中的血管生成与靶向治疗:从基础到临床实践
Clin Transl Med. 2025 Apr;15(4):e70313. doi: 10.1002/ctm2.70313.
5
Benign non-immune cells in tumor microenvironment.肿瘤微环境中的良性非免疫细胞。
Front Immunol. 2025 Apr 3;16:1561577. doi: 10.3389/fimmu.2025.1561577. eCollection 2025.
6
NKG2D ligand expression on NK cells induces NKG2D-mediated cross-tolerization of cytokine signaling and reduces NK cell tumor immunity.自然杀伤细胞(NK细胞)上NKG2D配体的表达会诱导细胞因子信号传导的NKG2D介导的交叉耐受,并降低NK细胞的肿瘤免疫。
J Immunol. 2025 Jun 1;214(6):1410-1421. doi: 10.1093/jimmun/vkaf030.
7
23ME-01473, an Fc Effector-Enhanced Anti-ULBP6/2/5 Antibody, Restores NK Cell-Mediated Antitumor Immunity through NKG2D and FcγRIIIa Activation.23ME - 01473,一种Fc效应增强型抗ULBP6/2/5抗体,通过激活NKG2D和FcγRIIIa恢复自然杀伤细胞介导的抗肿瘤免疫。
Cancer Res Commun. 2025 Mar 1;5(3):476-495. doi: 10.1158/2767-9764.CRC-24-0478.
8
The crossroad between tumor and endothelial cells.肿瘤细胞与内皮细胞的交叉路口。
Clin Exp Med. 2024 Sep 26;24(1):227. doi: 10.1007/s10238-024-01490-1.
9
CircARAP2 controls sMICA-induced NK cell desensitization by erasing CTCF/PRC2-induced suppression in early endosome marker RAB5A.环状 RNA ARAP2 通过消除 CTCF/PRC2 诱导的早期内体标记物 RAB5A 抑制来控制 sMICA 诱导的 NK 细胞脱敏。
Cell Mol Life Sci. 2024 Jul 24;81(1):307. doi: 10.1007/s00018-024-05285-1.
10
Signaling crosstalk between tumor endothelial cells and immune cells in the microenvironment of solid tumors.实体瘤微环境中肿瘤内皮细胞与免疫细胞之间的信号串扰。
Front Cell Dev Biol. 2024 Apr 25;12:1387198. doi: 10.3389/fcell.2024.1387198. eCollection 2024.
自身特异性激活受体 SLAM 家族对 NK 细胞的发育至关重要。
Immunity. 2016 Aug 16;45(2):292-304. doi: 10.1016/j.immuni.2016.07.013. Epub 2016 Aug 9.
4
Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I.细胞外MHC I类分子的结合增强了由细胞内MHC I类编程的人类自然杀伤细胞的成熟过程。
Immunity. 2016 Aug 16;45(2):280-91. doi: 10.1016/j.immuni.2016.07.005. Epub 2016 Aug 2.
5
NK cells and cancer: you can teach innate cells new tricks.自然杀伤细胞与癌症:你可以教先天细胞新招。
Nat Rev Cancer. 2016 Jan;16(1):7-19. doi: 10.1038/nrc.2015.5.
6
Dynamic Regulation of NK Cell Responsiveness.自然杀伤细胞反应性的动态调节
Curr Top Microbiol Immunol. 2016;395:95-114. doi: 10.1007/82_2015_485.
7
NKG2D Receptor and Its Ligands in Host Defense.宿主防御中的NKG2D受体及其配体
Cancer Immunol Res. 2015 Jun;3(6):575-82. doi: 10.1158/2326-6066.CIR-15-0098.
8
Roles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance induction.表达外周组织抗原的淋巴管内皮细胞在CD4 T细胞耐受性诱导中的作用。
Nat Commun. 2015 Apr 10;6:6771. doi: 10.1038/ncomms7771.
9
Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.抗肿瘤免疫。一种脱落的NKG2D配体,可促进自然杀伤细胞活化和肿瘤排斥。
Science. 2015 Apr 3;348(6230):136-9. doi: 10.1126/science.1258867. Epub 2015 Mar 5.
10
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors.细胞因子疗法可逆转 MHC 缺陷肿瘤中的自然杀伤细胞无反应性。
J Clin Invest. 2014 Nov;124(11):4781-94. doi: 10.1172/JCI74337. Epub 2014 Oct 20.